63546 Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 

based on this information and each 

application is scored and ranked. 

In addition, the following factors may 

affect the funding decision:

• Availability of funds 

• Relevance to program priorities. 

Applications will be funded in order 

by score and rank determined by the 

review panel. CDC/ATSDR will provide 

justification for any decision to fund out 

of rank order. 

V.3. Anticipated Announcement and 

Award Dates 

The anticipated announcement date is 

November 1, 2004 and the award dates 

will be 30–60 days before the 

conferences begin. 

VI. Award Administration Information 

VI.1. Award Notices 

Successful applicants will receive a 

Notice of Grant Award (NGA) from the 

CDC Procurement and Grants Office. 

The NGA shall be the only binding, 

authorizing document between the 

recipient and CDC. The NGA will be 

signed by an authorized Grants 

Management Officer, and mailed to the 

recipient fiscal officer identified in the 

application. 

Unsuccessful applicants will receive 

notification of the results of the 

application review by mail. 

VI.2. Administrative and National 

Policy Requirements 

45 CFR part 74 and part 92. 

For more information on the Code of 

Federal Regulations, see the National 

Archives and Records Administration at 

the following Internet address: http://

www.access.gpo.gov/nara/cfr/cfr-tablesearch.html.

The following additional 

requirements apply to this project: 

• AR–7 Executive Order 12372. 

• AR–9 Paperwork Reduction Act 

Requirements. 

• AR–10 Smoke-Free Workplace 

Requirements. 

• AR–11 Healthy People 2010. 

• AR–12 Lobbying Restrictions. 

• AR–13 Prohibition on Use of CDC 

Funds for Certain Gun Control 

Activities. 

• AR–15 Proof of Non-Profit Status. 

• AR–20 Conference Support. 

Additional information on these 

requirements can be found on the CDC 

Web site at the following Internet 

address: http://www.cdc.gov/od/pgo/

funding/ARs.htm.

VI.3. Reporting Requirements 

You must provide CDC with an 

original, plus two hard copies of the 

following reports: 

1. Interim progress report, due no less 

than 90 days before the end of the 

budget period. 

2. Financial status report, due no later 

than 90 days after the end of the budget 

period/project. 

These reports must be mailed to the 

Grants Management or Contract 

Specialist listed in the ‘‘Agency 

Contacts’’ section of this announcement. 

VII. Agency Contacts 

We encourage inquiries concerning 

this announcement. 

For general questions, contact: 

Technical Information Management 

Section, CDC Procurement and Grants 

Office, 2920 Brandywine Road, Atlanta, 

GA 30341, telephone: 770–488–2700. 

For program technical assistance, 

contact: Refer to the Attachment for 

contacts listed per each center. 

For business management assistance, 

contact: Edna Green, Grants 

Management Specialist, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341, 

telephone: 770–488–2743. e-mail: 

egreen@cdc.gov. 

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: http://www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: October 27, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

Attachment 

Topic Areas of Programmatic Interest and 

Contact Information 

100. Agency for Toxic Substances and 

Disease Registry (ATSDR)—LaShonda 

Billingsley, (404) 498–0275, 

LBillingsley@cdc.gov.

100.1 Health effects of hazardous 

substances in the environment; 

100.2 Disease and toxic substance exposure 

registries; 

100.3 Hazardous substance removal and 

remediation; 

100.4 Emergency Response to toxic and 

environmental disasters; 

100.5 Risk communication; 

100.6 Environmental Disease Surveillance; 

100.7 Investigation and research on 

hazardous substances in the environment 

300. National Center on Birth Defects and 

Developmental Disabilities (NCBDDD)—

Sheryl Heard, (404) 498–3978, 

SHeard@cdc.gov.

300.1 Birth Defects 

300.2 Fetal Alcohol Syndrome 

300.3 Disabilities: Issues related to people 

with disabilities; health promotion and 

intervention for persons with disabilities; 

secondary conditions; and aging and 

disability; 

300.4 Newborn and Childhood screening: 

Hearing, metabolic, genetic, and 

developmental 

300.5 Hearing Loss, early interventions, 

genetic causes 

300.6 Mental Retardation 

300.7 Child Development 

300.8 Autism Spectrum Disorders and 

Other Developmental Disabilities 

300.9 Hereditary Blood Disorders 

500. National Center for Environmental 

Health (NCEH)—LaShona Billingsley, (404) 

498–0275, LBillingsley@cdc.gov.

500.1 Genetics and Disease Prevention 

500.2 Emergency and Environmental Health 

Services (lead poisoning, environmental 

health hazards) 

500.3 Environmental Hazards and Health 

Effects (air pollution, asthma, health 

studies) 

500.4 Division of Laboratory Sciences (air 

toxins, newborn screening) 

600. National Center HIV, STD, and TB 

Prevention (NCHSTP)—Beth Wolfe, (404) 

639–8531, BWolfe@cdc.gov.

600.1 Sexually Transmitted Diseases (not 

HIV) 

600.2 Tuberculosis in Foreign Born Persons 

in the United States 

600.3 Tuberculosis in African American 

Populations in the United States 

(especially in the Southeast) 

600.4 Therapeutics and Diagnostics 

800.0 National Center for Injury Prevention 

and Control (NCIPC)—Benjamin Moore, 

(770) 488–4710, Moore@cdc.gov.

800.1 Unintentional Injuries Prevention 

800.2.1 National level conferences that 

focus on preventing child maltreatment 

before it occurs (primary prevention) 

800.2.2 National level conferences that 

focus on preventing youth violence before 

it occurs (primary prevention) 

800.3 Acute Injury Care 

800.4 Traumatic Brain Injury (TBI) 

800.5 Injury Related Disability 

800.6 Preparedness and Response for 

Injuries Resulting from Mass Causality 

Events and/or Terrorist Attacks 

800.7 Impact Biomechanics 

1500. Public Health Practice Program Office 

(PHPPO)—Janet Telman, (770) 488–2834, 

JTelman@cdc.gov.

1500.1 Laboratory Practice 

1500.2 Training and Materials

[FR Doc. 04–24390 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Task Force on Fetal Alcohol 

Syndrome and Fetal Alcohol Effect 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

Federal Register / Vol. 69, No. 211 / Tuesday, November 2, 2004 / Notices 63547

announces the following Federal 

advisory committee meeting.

NAME: National Task Force on Fetal 

Alcohol Syndrome and Fetal Alcohol 

Effect (NTFFASFAE).

TIMES AND DATES: 9 a.m.–4:30 p.m., 

December 6, 2004; 9 a.m.–12 noon, 

December 7, 2004.

PLACE: Westin Buckhead Atlanta Hotel, 

3391 Peachtree Road, NE., 30326, 

telephone (404) 365–0065, fax (404) 

365–8787.

STATUS: Open to the public, limited only 

by the space available. The meeting 

room accommodates approximately 65 

people.

PURPOSE: The Secretary is authorized by 

the Public Health Service Act, Section 

399G, (42 U.S.C. S 280f, as added by 

Public Law 105–392) to establish a 

National Task Force on Fetal Alcohol 

Syndrome and Fetal Alcohol Effect to: 

(1) Foster coordination among all 

governmental agencies, academic bodies 

and community groups that conduct or 

support Fetal Alcohol Syndrome (FAS) 

and Fetal Alcohol Effect (FAE) research, 

programs and surveillance; and(2) to 

otherwise meet the general needs of 

populations actually or potentially 

impacted by FAS and FAE.

MATTERS TO BE DISCUSSED: Agenda items 

include: An overview of effective 

strategies to reduce the risk of problem 

drinking and alcohol-exposed 

pregnancies; what is needed to 

implement effective programs in the 

service delivery system; alcohol 

advertising and adolescent girls; and a 

discussion of issues presented. 

Additional agenda items include: 

Prevention and Post-Exposure working 

group sessions; updates from Task Force 

members on current initiatives; an 

update on activities from the 

Interagency Coordinating Committee on 

Fetal Alcohol Syndrome, the CDC and 

other Federal agencies; future topics, 

and scheduling the next meeting. 

Agenda items are subject to change as 

priorities dictate.

FOR FURTHER INFORMATION CONTACT: R. 

Louise Floyd,DSN, RN, Designated 

Federal Official, National Center on 

Birth Defects and Developmental 

Disabilities, CDC, 1600Clifton Road, 

NE., (E–86), Atlanta, Georgia 30333, 

telephone (404) 498–3923, fax (404) 

498–3550. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register

notices pertaining to announcements of 

meetings and other committee 

management activities for both the CDC 

and ATSDR.

Dated: October 27, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24391 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

The Board of Scientific Counselors, 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) and the 

National Center for Environmental 

Health/Agency for Toxic Substances 

Disease Registry (ATSDR) announce the 

following committee meeting:

Name: Board of Scientific Counselors 

(BSC), National Center for Environmental 

Health/Agency for Toxic Substances 

andDisease Registry (NCEH/ATSDR). 

Time and Dates: 8:30 a.m.–5 p.m., 

November 18, 2004, 8:30 a.m.–12:30 p.m., 

November 19, 2004. 

Place: CDC Headquarters facility, 1600 

Clifton Road, Atlanta, GA 30333. 

Status: Open to the public for observation, 

limited only by the space available. The 

meeting room accommodates approximately 

100 people. 

Purpose: The Secretary, and by delegation, 

the Director of the Centers for Disease 

Control and Prevention and the 

Administrator of the National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry, are 

authorized under section 301 (42 U.S.C. 241) 

and section 311 (42 U.S.C. 243) of the Public 

Health Service Act, as amended, to (1) 

conduct, encourage, cooperate with, and 

assist other appropriate public authorities, 

scientific institutions, and scientists in the 

conduct of research, investigations, 

experiments, demonstrations, and studies 

relating to the causes, diagnosis, treatment, 

control, and prevention of physical and 

mental diseases and other impairments; (2) 

assist States and their political subdivisions 

in the prevention of infectious diseases and 

other preventable conditions and in the 

promotion of health and well-being; and (3) 

train State and local personnel in health 

work. The Board of Scientific Counselors, 

NCEH/ATSDR provides advice and guidance 

to the Secretary, HHS; the Director, CDC and 

Administrator, ATSDR; and the Director, 

NCEH/ATSDR, regarding program goals, 

objectives, strategies, and priorities in 

fulfillment of the agencies’ mission to protect 

and promote people’s health. The Board 

provides advice and guidance that will assist 

NCEH/ATSDR in ensuring scientific quality, 

timeliness, utility, and dissemination of 

results. The Board also provides guidance to 

help NCEH/ATSDR work more efficiently 

and effectively with its various constituents 

and to fulfill its mission in protecting 

America’s health. 

Matters To Be Discussed: The agenda items 

for the meeting on November 18–19, 2004, 

will include but are not limited to an update 

on future initiatives; update on NCEH/

ATSDR consolidation and accomplishments; 

reports on the Program Peer Review and the 

Community and Tribal subcommittees and 

the Health Department Workgroup; update 

on NCEH/ATSDR strategic priorities; report 

on social/behavioral sciences at NCEH/

ATSDR; a review of the ATSDR Draft Dioxin 

Soil Policy Guidelines; and a presentation on 

the Emergency Preparedness and Response 

activities at NCEH/ATSDR. 

Agenda items are tentative and subject to 

change. 

For Further Information Contact:

Individuals interested in attending the 

meeting, please contact Sandra Malcom, 

Committee Management Specialist, NCEH/

ATSDR, 1600 Clifton Road, Mail Stop E–28, 

Atlanta, GA 30303; telephone 404/498–0003, 

fax 404/498–0059; e-mail: smalcom@cdc.gov.

The deadline for notification of attendance is 

November 12, 2004. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the National Center for 

Environmental Health/Agency for 

ToxicSubstances and Disease Registry.

Dated: October 27, 2004. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention.

[FR Doc. 04–24389 Filed 11–1–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

[Docket No. 2002E–0340]

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; GANIRELIX ACETATE 

INJECTION (Formerly ANTAGON)

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) has determined 

the regulatory review period for 

GANIRELIX ACETATE INJECTION and 

is publishing this notice of that 

determination as required by law. FDA 

has made the determination because of 

the submission of an application to the 

Director of Patents and Trademarks, 

Department of Commerce, for the